CClinicalTrials.gg
CompletedNCT05832554Updated Jul 25, 2024

Comparison of the Effects of Nasal and Oral Airway Use on Gastric Insufflation

An interventional study of nasal airway and oral airway in Gastric Insufflation and Difficult Mask Ventilation, sponsored by Diskapi Teaching and Research Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years to 84 Years. Per ClinicalTrials.gov, last updated 2024-07-25.

Sponsored by Diskapi Teaching and Research Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
18 Years to 84 Years
Sex
All
01

Study summary

The goal of this clinical trial is to compare the effects of nasopharyngeal and oropharyngeal airway on gastric insufflation in patients undergoing general anesthesia and expected difficult mask ventilation. The main questions it aims to answer are:

  • Is there a difference between the presence of gastric insufflation in the use of nasopharyngeal and oropharyngeal airways?
  • Is there a difference between the antral area sizes measured before and after ventilation After general anesthesia induction, nasopharyngeal or oropharyngeal airway will be placed in participants and real-time ultrasonographic gastric antral area imaging will be performed during mask ventilation. Researchers will compare the effects of nasopharyngeal and oropharyngeal airway use on gastric insufflation.
Read the detailed description

Patients who are expected to have difficult mask ventilation and receive general anesthesia will be included in the study. After preoperative gastric antral area measurements of the patients by ultrasonography, preoxygenation will be applied and anesthesia induction will be performed. Real-time gastric ultrasonography will be performed during pressure-controlled mask ventilation for 2 minutes after nasopharyngeal or oropharyngeal airway insertion, and then antral area measurement will be repeated. After the trachea was intubated, the antral area measurement was once again performed. At the 30th, 60th, 90th and 120th seconds of ventilation, patients' SpO2, EtO2, EtCO2, peak airway pressure, tidal volume, leak volumes and hemodynamic changes will be recorded.

02

Conditions studied

  • Gastric Insufflation
  • Difficult Mask Ventilation

Keywords

  • Nasopharyngeal airway
  • Oropharyngeal airway
  • Difficult airway
03

In context

Lead sponsor

Diskapi Teaching and Research Hospital is the lead sponsor of 101 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 84 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients receiving general anesthesia
  • ASA score I-II-III
  • At least 3 criteria out of 5 difficult mask criteria defined by Langeron et al.

Exclusion criteria

Exclusion Criteria:

  • Patients who did not give informed consent
  • Risk of aspiration
  • Respiratory disease
  • Facial, oropharyngeal or nasopharyngeal pathology
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
58 participants (actual)

Study arms

  • Active comparator
    Nasopharyngeal airway

    Patients with nasopharygeal airway placed

    Device: nasal airway

  • Active comparator
    Orophryngeal airway

    Patients with oropharygeal airway placed

    Device: oral airway

Interventions

  • Devicenasal airway

    nasopharyngeal airway

  • Deviceoral airway

    oropharyngeal airway

06

What researchers measure

Primary outcomes

  1. Presence of gastric insufflation

    Presence of gastric insufflation by ultrasound imaging in nasopharyngeal and orophrayngeal airway use

    Time frame: During 2 minutes mask ventilation

  2. Difference in antral area sizes

    Difference in antral area sizes measured by ultrasound imaging before and after ventilation

    Time frame: During 2 minutes mask ventilation

Secondary outcomes

  1. Leakage volume

    Leakage volume per minute in nasopharyngeal and orophrayngeal airway use

    Time frame: During 2 minutes mask ventilation

07

Study locations

1 site
  • Ankara Etlik City Hospital
    Ankara, 06710, Turkey
08

References and documents

Publications

  • Bouvet L, Albert ML, Augris C, Boselli E, Ecochard R, Rabilloud M, Chassard D, Allaouchiche B. Real-time detection of gastric insufflation related to facemask pressure-controlled ventilation using ultrasonography of the antrum and epigastric auscultation in nonparalyzed patients: a prospective, randomized, double-blind study. Anesthesiology. 2014 Feb;120(2):326-34. doi: 10.1097/ALN.0000000000000094. PubMed 24317204 ↗
  • Langeron O, Masso E, Huraux C, Guggiari M, Bianchi A, Coriat P, Riou B. Prediction of difficult mask ventilation. Anesthesiology. 2000 May;92(5):1229-36. doi: 10.1097/00000542-200005000-00009. PubMed 10781266 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05832554
Lead sponsor
Diskapi Teaching and Research Hospital
Responsible party
derya özkan (Professor MD, Diskapi Teaching and Research Hospital) — Principal investigator
First posted
Apr 27, 2023
Start date
May 1, 2023
Primary completion
Nov 24, 2023
Completion
Jan 5, 2024
Last update
Jul 25, 2024

Study contacts

Derya Ozkan, proff MD
principal investigator · Ankara Etlik City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion